Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(36%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
29%
Ph not_applicable
10
71%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution14 total trials
Phase 4Post-market surveillance
4(28.6%)
N/ANon-phased studies
10(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

14

all time

Status Distribution
Active(7)
Completed(1)
Other(6)

Detailed Status

unknown6
Recruiting3
Active, not recruiting2
Completed1
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 44 (28.6%)
N/A10 (71.4%)

Trials by Status

active_not_recruiting214%
completed17%
recruiting321%
not_yet_recruiting17%
unknown643%
enrolling_by_invitation17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07258381Not Applicable

Mailuo Shutong Pills for Diabetic Wound Healing: A Multicenter Randomized Trial

Not Yet Recruiting
NCT07110415Phase 4

Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

Recruiting
NCT07135193Not Applicable

Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Athletes

Active Not Recruiting
NCT07135180Not Applicable

Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups

Active Not Recruiting
NCT04711889Not Applicable

Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)

Completed
NCT05339529Not Applicable

Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Recruiting
NCT06195267Not Applicable

Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)

Recruiting
NCT05688579Phase 4

Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia

Enrolling By Invitation
NCT05742230Not Applicable

Effect of Henagliflozin on Cardiac Function in Type 2 Diabetes Patients With Chronic Heart Failure (HERO-HF)

Unknown
NCT05487469Not Applicable

Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass

Unknown
NCT03789344Not Applicable

Randomized Controlled Trials of Electro-acupuncture Effects on Perioperative Anxiety in Patients Treated With PCI

Unknown
NCT02386943Phase 4

Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic Clamp

Unknown
NCT02190318Not Applicable

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Unknown
NCT01660386Phase 4

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"

Unknown

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14